South and Central America Non-Invasive Aesthetic Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Procedure (Injectables, Skin Rejuvenation, and Others) and End User (Hospitals, Clinics and Medical Spas, and Others)

The injectables segment by diagnosis is estimated to lead the market growth during the forecast period.

According to a new market research study of “South and Central America Non-Invasive Aesthetic Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Procedure, End-user and Country.” The South and Central America non-invasive aesthetic treatment market is expected to reach US$ 542.91 million by 2028 from US$ 274.29 million in 2021; it is estimated to grow at a CAGR of 10.2% from 2021 to 2028. The report highlights trends prevailing in South and Central America non-invasive aesthetic treatment market and the factors driving market along with those that act as hindrances.

The South and Central America non-invasive aesthetic treatment market based on the procedure was segmented into injectables, skin rejuvenation, and others. In 2020, the injectables segment held the largest share of the market, and same segment is expected to grow at the fastest rate during the coming years.

Non-invasive aesthetic treatments have gained popularity in the past few years due to advantages such as minimal downtime, no scars, low cost, and less complications. The popularity and acceptance of these procedures is mainly attributed to their noninvasiveness. Besides, it has been proved that the accuracy rate of minimally invasive surgeries is greater than that of open surgeries. Therefore, the advantages of minimally invasive procedures over conventional surgery - such as faster recovery, reduced pain, and shortened hospital stays, and greater efficiency rate - contribute to the non-invasive aesthetic treatment market growth. According to a recent report by the International Society of Aesthetic Plastic Surgery (2018), the total number of non-surgical procedures performed globally was above 12 million in 2018. The advancements in nonsurgical technologies and unveiling of new surgery options have made aesthetics accessible to people. For example, the advantages of laser procedures have attracted younger people to improve their skin conditions, modify body parts, and correct their physical posture. Therefore, rising acceptance of non-invasive aesthetic/cosmetic procedures is driving the growth of the South and Central America non-invasive aesthetic treatment market. Several government initiatives are helping in creating awareness regarding non-invasive aesthetic procedures among people, which is also boosting the market growth.

South and Central America is highly affected due to the COVID-19 outbreak pandemic. The outbreak has severely impacted the flow of medical services and medical tourism in the region. The Division of Plastic Surgery in Latin America suspended nonessential operations and outpatient consultations, achieving new guidelines (ANG) of national and international associations. Moreover, countries in this region are significantly dependent on the US and European countries for medical resources, which are under lockdown. Thus, the South and Central America non-invasive aesthetic treatment market in the region has experienced a significant slowdown and is expected to witness the same in the following two to three years.

The growth of the market is attributed to a few key driving factors such as rising number of non-invasive aesthetic/cosmetic procedures performed every year and surging awareness about cosmetic procedures among consumers. However, clinical risks and complications associated with medical aesthetic procedures is hindering the market growth.

Galderma, Alma Lasers, Merz Pharma, Bausch Health Companies Inc. Cutera Inc. Revance Therapeutics Inc. Cynosure, AbbVie Inc. Candela Medical and Johnson and Johnson Services, Inc. are among the leading companies operating in the South and Central America non-invasive aesthetic treatment market.

The report segments in South and Central America Non-Invasive Aesthetic Treatment Market as follows:

Procedure

• Injectables
• Botulinum Toxin
• Calcium Hydroxylapatite
• Hyaluronic Acid
• Polymer Filler
• Collagen
• Skin Rejuvenation
• Chemical Peel
• Laser Skin Resurfacing
• Photorejuvenation
• Others
• Hair Removal
• Nonsurgical Fat Reduction
• Sclerotherapy
• Cellulite Treatment

By End-user

• Hospitals
• Clinics and Medical Spas
• Others

By Country

• Brazil
• Argentina
• Rest of South and Central America

Reasons to buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America non-invasive aesthetic treatment market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the South and Central America non-invasive aesthetic treatment market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution